Candriam SCA’s BioLife Solutions BLFS Stock Holding History

Candriam SCA’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-45,000	Closed	-$1.3M	–	814
2020 Q3	$1.3M	Sell	45,000 -31,000	-41%	-$670K	0.01%	568
2020 Q2	$1.24M	Hold	76,000	–	–	0.01%	568
2020 Q1	$1.2M	Hold	76,000	–	–	0.01%	623
2019 Q4	$1.23M	Hold	76,000	–	–	0.01%	640
2019 Q3	$1.26M	Hold	76,000	–	–	0.02%	565
2019 Q2	$1.28M	Hold	76,000	–	–	0.02%	603
2019 Q1	$1.36M	Hold	76,000	–	–	0.02%	568
2018 Q4	$914K	Hold	76,000	–	–	0.01%	596
2018 Q3	$1.33M	Buy	+76,000	New	+$1.5M	0.02%	576

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Candriam SCA's BLFS Position: Q4 2020 in Review

Candriam SCA sold out of BioLife Solutions (BLFS) in Q4 2020, closing a stake of 45,000 shares — an estimated $1.3M sold.

Candriam SCA first reported a position in BLFS in Q3 2018 and held it in 9 quarters. The position peaked at $1.36M in Q1 2019. 128 funds tracked by Wall St. Rank hold BLFS as of Q4 2020.

Candriam SCA reported no remaining BioLife Solutions position as of Q4 2020 after selling out during the quarter.
Candriam SCA sold 45,000 BioLife Solutions shares in Q4 2020, an estimated $1.3M.
Candriam SCA first reported a position in BioLife Solutions in Q3 2018 and held it in 9 quarters.
Candriam SCA's BioLife Solutions position peaked at $1.36M in Q1 2019.
128 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2020.

Based on Candriam SCA's 13F filing for Q4 2020, filed 22 Jan 2021.